Refugees and Asylees: Recent Changes in Access to Health Coverage and Other Assistance
This issue brief provides an overview of refugees and asylees in the U.S., trends in…
This issue brief provides an overview of refugees and asylees in the U.S., trends in refugee and asylee admissions using data from the Department of Homeland Security (DHS), and recent changes in eligibility for assistance programs for refugees and asylees.
AI and advanced analytics can help organizations move beyond incremental fixes, streamlining access and improving patient experience, without overburdening staff or budgets. The post Simplifying Patient Access And Building Trust Using AI appeared first on MedCity News.
When doctors told her they had to remove her tongue and voice box to save her life from the cancer that had invaded her mouth, Sonya Sotinsky sat down with a microphone to record herself saying the things she would never again be able to say. “Happy birthday” and “I’m proud of you” topped the…
For nearly three years, Eric Tennant endured chemotherapy infusions, rounds of radiation, biopsies, and hospitalizations that left him weak and depleted. “It’s good to be home,” he said after one hospital stay in early June, “yet I’m tired and ready to get on with things.” In 2023, Tennant, of Bridgeport, West Virginia, was diagnosed with…
The top authorities of U.S. cancer statistics will soon have to classify the sex of patients strictly as male, female, or unknown, a change scientists and advocates say will harm the health of transgender people, one of the nation’s most marginalized populations. Scientists and advocates for trans rights say the change will make it much…
The CDC drew widespread criticism for updating its website with language suggesting a possible link between vaccines and autism, contradicting established science. The post Healthcare Organizations Slam CDC for Changing Website with Misleading Vaccine Claims appeared first on MedCity News.
A 2024 Data Quality Framework (DQF) from the European Medicines Agency (EMA) aims to provide some guidance for drug manufacturers. Here is a summary of that document. Factors to be considered when evaluating RWD Key factors to be considered in the EMA’s DQF include: Reliability: Are the data correct?Extensiveness: Are the data enoughCoherence: Are the…
About 22 million Americans would face sharply higher healthcare costs if enhanced ACA tax credits expire at the end of the year. Experts warn that the impact would extend beyond just families relying on ACA courage — also straining hospitals, increasing uncompensated care and potentially costing the economy hundreds of thousands of jobs. The post…
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
By KRISTINA SMITH & PHIYEN NGUYEN Policymakers and advocates often promote drug price transparency to lower costs and improve equity. While transparency is an important first step toward accountability and informed public budgeting, it does not guarantee affordable prices or fair access to medicines. Transparency Has Some Benefits Drug price transparency helps show how and…